{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T11:21:31Z","timestamp":1775733691287,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.cgh.2015.04.013","type":"journal-article","created":{"date-parts":[[2015,4,23]],"date-time":"2015-04-23T03:00:47Z","timestamp":1429758047000},"page":"1846-1853.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Association Between Severe Portal Hypertension and Risk of Liver Decompensation in Patients With Hepatitis C, Regardless of Response to Antiviral Therapy"],"prefix":"10.1016","volume":"13","author":[{"given":"Sabela","family":"Lens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Rinc\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montserrat","family":"Garc\u00eda-Retortillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agust\u00edn","family":"Albillos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Luis","family":"Calleja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Ba\u00f1ares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Gonz\u00e1lez","family":"Abraldes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaume","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Maria","family":"Sanchez-Tapias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Forns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carlos","family":"Garc\u00eda-Pag\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2015.04.013_bib1","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1053\/jhep.2000.19347","article-title":"Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C","volume":"32","author":"Poynard","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2015.04.013_bib2","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S0168-8278(01)00062-9","article-title":"Long-term beneficial effects in sustained responders to interferon-alfa therapy for chronic hepatitis C","volume":"34","author":"Bruno","year":"2001","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2015.04.013_bib3","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1046\/j.1365-2893.2003.00403.x","article-title":"Long-term liver histology improvement in patients with chronic hepatitis C and sustained response to interferon","volume":"10","author":"Toccaceli","year":"2003","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.cgh.2015.04.013_bib4","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2007.05.024","article-title":"Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis","volume":"133","author":"Ripoll","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2015.04.013_bib5","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1007\/s10620-006-9310-2","article-title":"Hepatic venous pressure gradient in cirrhosis: correlation with the size of varices, bleeding, ascites, and child's status","volume":"51","author":"Wadhawan","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2015.04.013_bib6","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jhep.2009.01.014","article-title":"Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis","volume":"50","author":"Ripoll","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2015.04.013_bib7","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/hep.21090","article-title":"Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation","volume":"43","author":"Blasco","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2015.04.013_bib8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/gut.50.3.425","article-title":"Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?","volume":"50","author":"Burroughs","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2015.04.013_bib9","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1111\/j.1572-0241.2006.00743.x","article-title":"Antiviral therapy decreases hepatic venous pressure gradient in patients with chronic hepatitis C and advanced fibrosis","volume":"101","author":"Rincon","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2015.04.013_bib10","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1056\/NEJMoa1402454","article-title":"Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection","volume":"370","author":"Afdhal","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2015.04.013_bib11","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJMoa1316366","article-title":"Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection","volume":"370","author":"Afdhal","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2015.04.013_bib12","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1056\/NEJMoa1402869","article-title":"ABT-450\/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis","volume":"370","author":"Poordad","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2015.04.013_bib13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1155\/2011\/954812","article-title":"Non-invasive diagnostic and prognostic evaluation of liver cirrhosis and portal hypertension","volume":"31","author":"Berzigotti","year":"2011","journal-title":"Dis Markers"},{"key":"10.1016\/j.cgh.2015.04.013_bib14","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jhep.2014.05.042","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases","volume":"61","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2015.04.013_bib15","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2010.05.004","article-title":"EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis","volume":"53","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2015.04.013_bib16","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jhep.2010.06.004","article-title":"Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension","volume":"53","author":"de Franchis","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2015.04.013_bib17","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","article-title":"Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver","volume":"35","author":"Bruix","year":"2001","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2015.04.013_bib18","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.20933","article-title":"Management of hepatocellular carcinoma","volume":"42","author":"Bruix","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2015.04.013_bib19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cgh.2007.10.021","article-title":"Influence of cannabis use on severity of hepatitis C disease","volume":"6","author":"Ishida","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2015.04.013_bib20","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/apt.12721","article-title":"Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients","volume":"39","author":"D'Amico","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2015.04.013_bib21","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1055\/s-0034-1371011","article-title":"Interferon-free regimens in the liver-transplant setting","volume":"34","author":"Lens","year":"2014","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cgh.2015.04.013_bib22","first-page":"320A","article-title":"Ledipasvir\/sofosbuvir with ribavirin for the treatment of HCV in patients with decompensated cirrhosis: preliminary results of a prospective, multicenter study","volume":"60","author":"Flamm","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2015.04.013_bib23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/hep.21941","article-title":"Platelet count is not a predictor of the presence or development of gastroesophageal varices in cirrhosis","volume":"47","author":"Qamar","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2015.04.013_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2893.2010.01366.x","article-title":"Prevalence of thrombocytopenia among patients with chronic hepatitis C: a systematic review","volume":"18","author":"Louie","year":"2011","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.cgh.2015.04.013_bib25","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/apt.12273","article-title":"Long-term outcome of chronic hepatitis C after sustained virological response to interferon-based therapy","volume":"37","author":"Koh","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2015.04.013_bib26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-158-5-201303050-00005","article-title":"Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies","volume":"158","author":"Morgan","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2015.04.013_bib27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.antiviral.2014.03.012","article-title":"Reversal, maintenance or progression: what happens to the liver after a virologic cure of hepatitis C?","volume":"107C","author":"Lee","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.cgh.2015.04.013_bib28","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1053\/j.gastro.2004.03.009","article-title":"Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking","volume":"126","author":"Issa","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2015.04.013_bib29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jhep.2011.06.027","article-title":"Assessment of portal hypertension by transient elastography in patients with compensated cirrhosis and potentially resectable liver tumors","volume":"56","author":"Llop","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2015.04.013_bib30","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/liv.12522","article-title":"A\u00a0prospective observational study on tolerance and satisfaction to hepatic haemodynamic procedures","volume":"35","author":"Casu","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2015.04.013_bib31","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMoa044456","article-title":"Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis","volume":"353","author":"Groszmann","year":"2005","journal-title":"N\u00a0Engl J Med"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356515004152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356515004152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:17:27Z","timestamp":1761542247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356515004152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S1542356515004152"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2015.04.013","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association Between Severe Portal Hypertension and Risk of Liver Decompensation in Patients With Hepatitis C, Regardless of Response to Antiviral Therapy","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2015.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 AGA Institute. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}